It can be used as both injection-type or oral-type drug.[9] The marketing authorization in EU was granted on 8 February 2018.[10] It is still under review by regulatory authorities in Japan, pending approval.[11] ------------------------------------- Reported by Jules Levin AASLD 2018 Nov 9-13 SF Philip N Newsome1 ,2, Stephen A Harrison3, Sren Rasmussen4, Tea Monk Fries4, Luc Van Gaal5 1National Institute for Health Research Birmingham Biomedical Research Centre and Liver Unit at University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
They were also 50% less likely to die of a drug overdose or other SUD-related cause
Combining the two could theoretically worsen these symptoms, though this has not been formally studied
The hormone is quite similar to a hunger-regulating hormone humans harbor in the small intestine, which helps control blood sugar levels
They may complement each other rather than compete
This not only aids individuals who grapple with cravings and food addiction but also contributes to more effective appetite control